Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer

This publication has 21 references indexed in Scilit:

• Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate
  Urology, 2003
• In regard to Kupelian et al.: impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. IJROBP 2002;52:704-711.
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Practical application of biochemical failure definitions: what to do and when to do it
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Definitions of biochemical failure in prostate cancer following radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results
  Urology, 1999
• The Correlation Between the Astro Consensus Panel Definition of Biochemical Failure and Clinical Outcome for Patients with Prostate Cancer Treated with External Beam Irradiation
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Significance of ipsilateral breast tumour recurrence after lumpectomy
  The Lancet, 1991